+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aripiprazole"

From
ABILIFY MYCITE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ABILIFY MYCITE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
From
Serotonin receptor 2 angonist - Pipeline Insight, 2024 - Product Thumbnail Image

Serotonin receptor 2 angonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 92 Pages
  • China
From
From
United States VRAYLAR Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States VRAYLAR Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
From
Disease Analysis: Schizophrenia - Product Thumbnail Image

Disease Analysis: Schizophrenia

  • Report
  • March 2021
  • 101 Pages
  • Global
Schizophrenia Disease Coverage to 2024 - Product Thumbnail Image

Schizophrenia Disease Coverage to 2024

  • Report
  • July 2019
  • 498 Pages
  • Global
Abilify/Abilify Maintena Drug Overview 2019 - Product Thumbnail Image

Abilify/Abilify Maintena Drug Overview 2019

  • Report
  • March 2019
  • 62 Pages
  • Global
Rexulti (brexpiprazole) Drug Overview 2019 - Product Thumbnail Image

Rexulti (brexpiprazole) Drug Overview 2019

  • Report
  • March 2019
  • 33 Pages
  • Global
Drug Overview: Aristada - Product Thumbnail Image

Drug Overview: Aristada

  • Report
  • March 2018
  • 16 Pages
  • Global
From
Mental Illness Drugs Markets in China - Product Thumbnail Image

Mental Illness Drugs Markets in China

  • Report
  • November 2023
  • 251 Pages
  • China
From
Loading Indicator

Aripiprazole is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a dopamine partial agonist, meaning it works by stimulating dopamine receptors in the brain. Aripiprazole is also used to treat irritability and symptoms associated with autism spectrum disorder. It is available in both oral and injectable forms. Aripiprazole is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also less likely to cause weight gain and metabolic changes than other antipsychotics. The aripiprazole market is highly competitive, with many companies offering generic versions of the drug. Companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals are some of the major players in the market. Other companies such as Dr. Reddy's Laboratories, Lupin, and Torrent Pharmaceuticals also offer generic versions of the drug. Show Less Read more